Ingevity Corp.
- NGVT ยท NYSE
- Chemicals & Allied Products
- North Charleston, SC
- 1,500 employees
- CIK 0001653477
Updated from SEC filings through
Top things to know
Executives
- David H. Li President & CEO 4, 2026-08-18
- Phillip John Platt SVP, Chief Financial Officer 4, 2026-08-11
- Mary Dean Hall EVP, Chief Financial Officer 4, 2026-03-03
- CEO Dave Li Ingevity President and 8-K, 2026-11-04
- Ryan Cotterman Vice President, Chief Accounting Officer and principal accounting officer 8-K, 2026-06-24
- Ryan Joseph Cotterman VP, Chief Accounting Officer 4, 2026-06-24
What leadership is saying
“Third quarter results reflect disciplined execution across the portfolio amid a mixed global demand environment”
Earnings press release (8-K Ex. 99.1), filed November 4, 2026
Ingevity Corp is a U.S. public company in chemicals & allied products (SIC 2800), headquartered in North Charleston, SC. It trades as NGVT on NYSE. Revenue was $1.2B in the fiscal year ending December 31, 2025, -2.7% from the year before. It reported about 1,500 employees. David H. Li is President & CEO.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.2B 10-K, 2026-02-26 | $1.2B 10-K, 2026-02-26 | $1.2B 10-K, 2026-02-26 | $1.7B 10-K, 2025-02-19 | $1.4B 10-K, 2024-02-22 |
| Operating income | $419M 10-K, 2026-02-26 | $426M 10-K, 2026-02-26 | $423M 10-K, 2026-02-26 | $453M 10-K, 2025-02-19 | $422M 10-K, 2024-02-22 |
| SG&A | $171M 10-K, 2026-02-26 | $158M 10-K, 2026-02-26 | $162M 10-K, 2026-02-26 | $199M 10-K, 2025-02-19 | $179M 10-K, 2024-02-22 |
| Net income | -$167M 10-K, 2026-02-26 | -$430M 10-K, 2026-02-26 | -$5.4M 10-K, 2026-02-26 | $212M 10-K, 2025-02-19 | $118M 10-K, 2024-02-22 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| David H. Li | President & CEO | 4, 2026-08-18 |
| Luis Fernandez-Moreno | Named in proxy bio: Interim President & Chief Executive Officer | DEF 14A, 2026-03-17 |
| Phillip John Platt | SVP, Chief Financial Officer | 4, 2026-08-11 |
| Mary Dean Hall CFO at Ingevity Corp (Retired) | EVP, Chief Financial Officer | 4, 2026-03-03 |
| CEO Dave Li | Ingevity President and | 8-K, 2026-11-04 |
| Ryan Cotterman Senior Finance and Accounting Leader | Strategic | Global Mindset | Business Transformation | Operational Excellence | NC Certified Public Accountant (CPA) | Vice President, Chief Accounting Officer and principal accounting officer | 8-K, 2026-06-24 |
| Ryan Joseph Cotterman | VP, Chief Accounting Officer | 4, 2026-06-24 |
| Terrance M. Dyer | SVP, Chief HR Officer | 4, 2026-06-01 |
| Phillip J. Platt Senior Vice President of Finance and Chief Accounting Officer at Ingevity | Named in proxy bio: Senior Vice President, Finance, and Chief Accounting Officer | DEF 14A, 2026-03-17 |
| TERRY DYER Global Human Resources Executive | CHRO | Strategic Business Partner | Transformation Leader | Performance Culture Champion | Authentic Servant Leader | Inclusi | Named in proxy bio: Senior Vice President, Chief Human Resources Officer | DEF 14A, 2026-03-17 |
| RICHARD A. WHITE | Named in proxy bio: Senior Vice President & President, Performance Chemicals | DEF 14A, 2026-03-17 |
| S. Edward Woodcock | Named in proxy bio: Executive Vice President & President, Performance Materials | DEF 14A, 2026-03-17 |
| Ryan C. Fisher Senior Vice President, General Counsel and Corporate Secretary at Ingevity | SVP, Gen. Counsel & Secretary | 4, 2026-08-04 |
| BENJAMIN G. (SHON) WRIGHT | Board member (per proxy) bio: IND | DEF 14A, 2026-03-17 |
| F. DAVID SEGAL | Board member (per proxy) bio: IND | DEF 14A, 2026-03-17 |
| FREDERICK J. LYNCH | Board member (per proxy) bio: IND | DEF 14A, 2026-03-17 |
What Ingevity Corp does
Ingevity Corporation provides products and technologies that purify, protect, and enhance the world around us. Through a diverse team of talented and experienced people, we develop, manufacture, and bring to market solutions that are largely renewably sourced and help customers solve complex problems while making the world more sustainable.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 33.8 million (as of November 3, 2026) | 10-Q, November 5, 2026 |
|---|---|---|
| Public float | $1.6B (as of June 30, 2025) | 10-K, February 26, 2026 |
| Reportable segments | 3 (period ending September 30, 2026) | 10-Q, November 5, 2026 |
| Latest proxy statement | Meeting April 29, 2026 (filed March 17, 2026) | DEF 14A, March 17, 2026 |
| Auditor | PricewaterhouseCoopers LLP (Charlotte, North Carolina) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| August 18, 2026 | David H. Li President & CEO | Sale | 10,092 | $765K | Form 4, August 18, 2026 |
| August 13, 2026 | David H. Li President & CEO | Sale | 10,000 | $762K | Form 4, August 14, 2026 |
| August 3, 2026 | Ryan C. Fisher SVP, Gen. Counsel & Secretary | Sale | 2,709 | $200K | Form 4, August 4, 2026 |
| May 28, 2026 | Terrance M. Dyer SVP, Chief HR Officer | Sale | 496 | $34K | Form 4, June 1, 2026 |
Recent 8-K events
- 8-K filed 2026-11-04
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-07-29
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-06-24
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-05-06
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-05-04
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-04-15
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-03-30
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- 8-K filed 2026-02-25
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-02-23
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-01-05
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
- Item 7.01 Regulation FD disclosure
Frequently asked questions about Ingevity Corp
- What does Ingevity Corp do?
- In its own words, from Item 1 of its 10-K: "Ingevity Corporation provides products and technologies that purify, protect, and enhance the world around us. Through a diverse team of talented and experienced people, we develop, manufacture, and bring to market solutions that are largely renewably sourced and help customers solve complex problems while making the world more sustainable."
- What is Ingevity Corp's revenue?
- $1.2B for the fiscal year ending December 31, 2025, from its 10-K filed February 26, 2026.
- Is Ingevity Corp profitable?
- Ingevity Corp reported net income of -$167M for the fiscal year ending December 31, 2025.
- How many employees does Ingevity Corp have?
- About 1,500 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Ingevity Corp?
- David H. Li, President & CEO, as named in a 4 filed August 18, 2026.
- Who is the CFO of Ingevity Corp?
- Phillip John Platt, SVP, Chief Financial Officer, as named in a 4 filed August 11, 2026.
- Where is Ingevity Corp headquartered?
- North Charleston, SC.
- What is Ingevity Corp's stock ticker?
- NGVT on NYSE.
- What industry is Ingevity Corp in?
- Chemicals & Allied Products, SIC code 2800.
- What is Ingevity Corp's website?
- ingevity.com.
- When does Ingevity Corp report earnings next?
- February 10, 2027. Source: estimate_8k_pattern.
- Is Ingevity Corp a public company?
- Yes. Ingevity Corp files with the SEC under CIK 0001653477 and trades as NGVT.
- Who audits Ingevity Corp?
- PricewaterhouseCoopers LLP, Charlotte, North Carolina, as named in its latest annual report (10-K).
- How many shares of Ingevity Corp are outstanding?
- 33.8 million shares as of November 3, 2026, from its 10-Q filed November 5, 2026.
- What is Ingevity Corp's public float?
- $1.6B as of June 30, 2025, as reported on the cover of its 10-K filed February 26, 2026.
- How many business segments does Ingevity Corp report?
- 3 reportable segments for the period ending September 30, 2026, from its 10-Q filed November 5, 2026.
- When is Ingevity Corp's annual shareholder meeting?
- April 29, 2026, per its proxy statement (DEF 14A) filed March 17, 2026.
- Have Ingevity Corp insiders traded stock recently?
- Since May 28, 2026, officers and directors reported 4 open-market sales worth about $1.8M and 0 purchases on Forms 4 and 5. The most recent: David H. Li (President & CEO) sold 10,092 shares on August 18, 2026.